Literature DB >> 28752459

Expression and Purification of Active Recombinant Human Alpha-1 Antitrypsin (AAT) from Escherichia coli.

Beena Krishnan1, Lizbeth Hedstrom2,3, Daniel N Hebert4, Lila M Gierasch4,5, Anne Gershenson4.   

Abstract

Well-established genetic manipulation procedures along with a fast doubling time, the ability to grow in inexpensive media, and easy scaleup make Escherichia coli (E. coli) a preferred recombinant protein expression platform. Human alpha-1 antitrypsin (AAT) and other serpins are easily expressed in E. coli despite their metastability and complicated topology. Serpins can be produced as soluble proteins or aggregates in inclusion bodies, and both forms can be purified to homogeneity. In this chapter, we describe an ion-exchange chromatography-based protocol that we have developed involving the use of two anion-exchange columns to purify untagged human AAT from E. coli. We also outline methods that can be used to determine the inhibitory activity of both AAT in cell lysates and purified AAT. Our protocol for the purification of bacterially expressed AAT yields pure and active protein at 6-7 mg/l culture.

Entities:  

Keywords:  Absorbance spectroscopy; Alpha-1 antitrypsin (AAT); Anion-exchange chromatography; Elastase; Stoichiometry of inhibition; Trypsin

Mesh:

Substances:

Year:  2017        PMID: 28752459      PMCID: PMC5906034          DOI: 10.1007/978-1-4939-7163-3_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  Production of recombinant serpins in Escherichia coli.

Authors:  Mary C Pearce; Lisa D Cabrita
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  How the serpin α1-proteinase inhibitor folds.

Authors:  Klavs Dolmer; Peter G W Gettins
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

4.  High-level production of fully active human alpha 1-antitrypsin in Escherichia coli.

Authors:  H Johansen; J Sutiphong; G Sathe; P Jacobs; A Cravador; A Bollen; M Rosenberg; A Shatzman
Journal:  Mol Biol Med       Date:  1987-10

5.  Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.

Authors:  Alexey Dementiev; József Dobó; Peter G W Gettins
Journal:  J Biol Chem       Date:  2005-12-01       Impact factor: 5.157

Review 6.  Conformational pathology of the serpins: themes, variations, and therapeutic strategies.

Authors:  Bibek Gooptu; David A Lomas
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

7.  Refolding of alpha 1-antitrypsin expressed as inclusion bodies in Escherichia coli: characterization of aggregation.

Authors:  K S Kwon; S Lee; M H Yu
Journal:  Biochim Biophys Acta       Date:  1995-03-15

Review 8.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins.

Authors:  R Huber; R W Carrell
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

9.  Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin.

Authors:  H L James; A B Cohen
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation.

Authors:  F C Peterson; N C Gordon; P G Gettins
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

View more
  2 in total

Review 1.  Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques.

Authors:  Benjamin M Scott; William P Sheffield
Journal:  Protein Sci       Date:  2019-12-09       Impact factor: 6.725

2.  Enhanced secretion of human α1-antitrypsin expressed with a novel glycosylation module in tobacco BY-2 cell culture.

Authors:  Ningning Zhang; Tristen Wright; Paige Caraway; Jianfeng Xu
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.